Evidence map›Paper›PMID 31502503›Full record

Trial reportThe Journal of international medical research2019

A phase II trial of cabazitaxel as second line chemotherapy in relapsed locally advanced and/or metastatic carcinoma of the penis.

Amarnath Challapalli, Sylvia Pearson, Anita V Mitra, Marc Coe, Alastair Thomson, Tony Elliott, Peter Kirkbride, Lisa Pickering, Hannah Kirk, Emily Foulstone and 3 more

Open access · goldAbstract readClinical Trial, Phase IIMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Trial report in The Journal of international medical research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Penile cancer: Updates in systemic therapy.Asian journal of urology · 2022
    Review
  4. Immune-based therapies in penile cancer.Nature reviews. Urology · 2022
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Amarnath ChallapalliDepartment of Clinical Oncology, Bristol Cancer Institute, Bristol, UK.ORCID https://orcid.org/0000-0002-3683-9583
Sylvia PearsonDepartment of Clinical Oncology, Bristol Cancer Institute, Bristol, UK.
Anita V MitraUniversity College London Hospitals NHS Foundation Trust, London, UK.
Marc CoeDepartment of Clinical Oncology, Bristol Cancer Institute, Bristol, UK.
Alastair ThomsonRoyal Cornwall Hospitals NHS Trust, Truro, UK.
Tony ElliottThe Christie NHS Foundation Trust, Manchester, UK.
Peter KirkbrideThe Clatterbridge Cancer Centre NHS Foundation Trust, The Wirral, UK.
Lisa PickeringSt Georges University Hospitals NHS Foundation Trust, London, UK.
Hannah KirkDepartment of Clinical Oncology, Bristol Cancer Institute, Bristol, UK.
Emily FoulstoneDepartment of Clinical Oncology, Bristol Cancer Institute, Bristol, UK.
Heidi EvansDepartment of Clinical Oncology, Bristol Cancer Institute, Bristol, UK.
Alicia BravoDepartment of Clinical Oncology, Bristol Cancer Institute, Bristol, UK.
Amit K BahlDepartment of Clinical Oncology, Bristol Cancer Institute, Bristol, UK.
Clatterbridge Cancer Centre NHS Foundation Trust · GBRoyal Cornwall Hospital Trust · GBSt George’s University Hospitals NHS Foundation Trust · GBThe Christie NHS Foundation Trust · GBUniversity College London Hospitals NHS Foundation Trust · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdultAgedHumansMaleMiddle AgedNeoplasm StagingPenile NeoplasmsQuality of LifeRecurrenceTaxoidsTreatment OutcomecabazitaxelTaxoidsAdvanced penile cancercabazitaxelmetastasisobjective response rateoverall survivalprogression-free survivalsecond line chemotherapy

Identifiers

PMID31502503
PMCPMC6833416
OpenAlexW2972824578

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.